Glazer Capital LLC’s Science Strategic Acquisition Corp. Alpha Class A Common Stock SSAA Stock Holding History

Glazer Capital LLC’s Portfolio SSAA Stock Details SSAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,865,684	Closed	-$18.4M	–	713
2022 Q3	$18.4M	Buy	1,865,684 +8,616	+0.5%	+$84.9K	0.34%	92
2022 Q2	$18.2M	Buy	1,857,068 +26,417	+1%	+$259K	0.45%	60
2022 Q1	$18M	Buy	1,830,651 +14,689	+0.8%	+$143K	0.5%	57
2021 Q4	$17.7M	Buy	1,815,962 +1,774,483	+4,278%	+$17.4M	0.43%	62
2021 Q3	$403K	Buy	41,479 +4,211	+11%	+$40.9K	0.01%	579
2021 Q2	$361K	Buy	37,268 +5,286	+17%	+$51.7K	0.01%	676
2021 Q1	$307K	Buy	+31,982	New	+$312K	﹤0.01%	630

Glazer Capital LLC's SSAA Position: Q4 2022 in Review

Glazer Capital LLC sold out of Science Strategic Acquisition Corp. Alpha Class A Common Stock (SSAA) in Q4 2022, closing a stake of 1,865,684 shares — an estimated $18.4M sold.

Glazer Capital LLC first reported a position in SSAA in Q1 2021 and held it in 7 quarters. The position peaked at $18.4M in Q3 2022. 0 funds tracked by Wall St. Rank hold SSAA as of Q4 2022.

Glazer Capital LLC reported no remaining Science Strategic Acquisition Corp. Alpha Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Glazer Capital LLC sold 1,865,684 Science Strategic Acquisition Corp. Alpha Class A Common Stock shares in Q4 2022, an estimated $18.4M.
Glazer Capital LLC first reported a position in Science Strategic Acquisition Corp. Alpha Class A Common Stock in Q1 2021 and held it in 7 quarters.
Glazer Capital LLC's Science Strategic Acquisition Corp. Alpha Class A Common Stock position peaked at $18.4M in Q3 2022.
0 funds tracked by Wall St. Rank held Science Strategic Acquisition Corp. Alpha Class A Common Stock as of Q4 2022.

Based on Glazer Capital LLC's 13F filing for Q4 2022, filed 14 Feb 2023.